Novartis Pharmaceuticals Corporation

FDA Regulatory Profile

Novartis Pharmaceuticals Corporation has 33 FDA recalls (3 Class I), 54 inspections, 0 510(k) clearances and 0 compliance actions on record.

What these totals cover: FDA records filed under the name "Novartis Pharmaceuticals Corporation" and its spelling variant "Novartis Pharmaceuticals". Records filed under related names are not included; see Related names.

Latest recall
D-0746-2026 · Class II · Aug 4, 2026
Latest inspection
Jun 24, 2026 · NAI

Reviewing Novartis Pharmaceuticals Corporation as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Novartis Pharmaceuticals Corporation yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls33 (3 Class I)Nov 8, 2026File dated Nov 3, 2026Current
510(k) clearances0Nov 8, 2026File dated Nov 2, 2026Current
Inspections54Nov 13, 2026Newest record Nov 5, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Novartis Pharmaceuticals Corporation's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Novartis Pharmaceuticals Corporation: FDA inspections per year 2017: 2 inspections220172018: 3 inspections320182019: 3 inspections320192020: 1 inspections120202021: 2 inspections220212022: 1 inspections120222023: 3 inspections320232024: 4 inspections420242025: 3 inspections320252026: 2 inspections22026
YearInspectionsOAIWarning lettersRecall recordsClass I
202620010
202530000
202440000
202330022
202210050
202120000
202010000
201930011
201830000
201720020

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Recent recalls

33 recall records from Aug 8, 2013 to Aug 4, 2026. Showing the 20 most recent. View all 33 recall records

NumberClassProductDate
D-0746-2026Class IIDiovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC…Aug 4, 2026
D-0144-2024Class ISANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle, Rx Only…Nov 22, 2023
D-1174-2023Class ISANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle, Rx Only…Sep 8, 2023
D-1543-2022Class IINeoral soft gelatin capsules (cyclosporine capsules, USP) Modified, 25 mg, Rx Only, 30 Soft Gelatin…Sep 16, 2022
D-0983-2022Class IIIXiidra (lifitegrast ophthalmic solution) 5%, packaged in a) 60 Single-Use Containers: 12 pouches x 5…May 10, 2022
D-0982-2022Class IIIXiidra (lifitegrast ophthalmic solution), packaged in a) 60 Single-Use Containers: 12 pouches x 5…May 10, 2022
D-0984-2022Class IIIXiidra (lifitegrast ophthalmic solution) 5% PROFESSIONAL SAMPLE, packaged in a) 5 single-use…May 10, 2022
D-0985-2022Class IIIXiidra (lifitegrast ophthalmic solution) 5% PROFESSIONAL SAMPLE, packaged in a) 5 single-use…May 10, 2022
D-1309-2019Class IPromacta (eltrombopag) 12.5 mg for Oral Suspension, Rx Only Manufactured by: Halo Pharmaceuticals…May 11, 2019
D-0679-2017Class IIIPilocarpine Hydrochloride Ophthalmic Solution 4% , packaged in 15 mL bottles, Rx Only, Manufactured…Mar 22, 2017
D-0678-2017Class IIIIsopto Carpine (pilocarpine hydrochloride opthalmic solution) 4%, packaged in 15 mL bottle, Rx only…Mar 22, 2017
D-1430-2015Class IIIDexmethylphenidate HCl Extended-Release, Capsules, 10mg, Rx only, 100 Capsules. Manufactured by…Jul 28, 2015
D-1138-2015Class IIIForadil Aerolizer (formoterol fumarate inhalation powder) 12 mcg per capsule, 60 Capsules (Blister…May 22, 2015
D-1137-2015Class IIIForadil Aerolizer (formoterol fumarate inhalation powder) 12 mcg per capsule, 12 Capsules (Blister…May 22, 2015
D-1516-2014Class IIICataflam (diclofenac potassium) tablets, 50 mg, 100-count bottles, Rx only, Manufactured by: Patheon…Jul 30, 2014
D-1387-2014Class IIIForadil Aerolizer (formoterol fumarate inhalation powder), 12 mcg per capsule, 60 Capsules, Rx only…May 28, 2014
D-1227-2014Class IIIRitalin HCl (methylphenidate HCl) USP, 10 mg, 100 tablets per Bottle, Rx only, Mfd. by: Novartis…Mar 3, 2014
D-1228-2014Class IIIRitalin HCl (methylphenidate HCl) USP, 20 mg, 100 tablets per Bottle, Rx only, Mfd. by: Novartis…Mar 3, 2014
D-337-2014Class IITekturna (aliskiren) Tablets 150 mg, 7 tablets per bottle, Physician Sample-Not For Sale, Rx only…Aug 8, 2013
D-336-2014Class IIStalevo (carbidopa, levodopa, and entacapone) 12.5/50/200 mg, 7 tablets per bottle, Physician…Aug 8, 2013

Recent FDA inspections

54 inspections from Nov 18, 2008 to Jun 24, 2026. Showing the 20 most recent. View all 54 inspections

DateSiteProductClassificationFEI
Jun 24, 2026East Hanover, NJDrugsNo Action Indicated (NAI)2210396
Feb 6, 2026Morris Plains, NJBiologicsVoluntary Action Indicated (VAI)3010353512
Jul 11, 2025Targu Mures, RomaniaDrugsVoluntary Action Indicated (VAI)3005587283
Jun 25, 2025East Hanover, NJDrugsNo Action Indicated (NAI)2210396
Mar 3, 2025East Hanover, NJDrugsNo Action Indicated (NAI)2210396
Nov 19, 2024East Hanover, NJDrugsNo Action Indicated (NAI)2210396
Aug 29, 2024East Hanover, NJDrugsNo Action Indicated (NAI)2210396
Aug 8, 2024Morris Plains, NJBiologicsVoluntary Action Indicated (VAI)3010353512
Jun 27, 2024East Hanover, NJDrugsNo Action Indicated (NAI)2210396
Aug 26, 2023Targu Mures, RomaniaDrugsVoluntary Action Indicated (VAI)3005587283
Aug 21, 2023East Hanover, NJDrugsVoluntary Action Indicated (VAI)2210396
Jun 13, 2023East Hanover, NJDrugsNo Action Indicated (NAI)2210396
Dec 9, 2022Morris Plains, NJBiologicsVoluntary Action Indicated (VAI)3010353512
Jul 9, 2021East Hanover, NJDrugsNo Action Indicated (NAI)2210396
Mar 3, 2021East Hanover, NJDrugsNo Action Indicated (NAI)2210396
Jul 2, 2020East Hanover, NJDrugsNo Action Indicated (NAI)2210396
Aug 21, 2019Morris Plains, NJBiologicsVoluntary Action Indicated (VAI)3010353512
Jul 2, 2019East Hanover, NJDrugsVoluntary Action Indicated (VAI)2210396
Feb 21, 2019East Hanover, NJDrugsNo Action Indicated (NAI)2210396
Dec 14, 2018East Hanover, NJDrugsVoluntary Action Indicated (VAI)2210396
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

5 inspected sites, newest inspection first.

FacilityLocationInspectionsLatest
FEI 2210396East Hanover, NJ30Jun 24, 2026
FEI 3010353512Morris Plains, NJ4Feb 6, 2026
FEI 3005587283Targu Mures, Romania4Jul 11, 2025
FEI 2416082Suffern, NY9Jul 14, 2015
FEI 3000215618Vacaville, CA7Nov 2, 2012

Need more than this page shows? Ask about Novartis Pharmaceuticals Corporation in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.